EDIT
Editas Medicine Inc
2.80$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.4% | 2.4% | 124.1% | 276.8% | 2,621.3% | 158.8% | 570.9% | 452.2% | 262.2% | 3.3% | 17.1% | – | – | |
| 71.6% | 97.6% | -24.1% | -176.8% | -2,521.3% | -58.8% | -470.9% | -352.2% | -162.2% | 100.0% | 82.9% | 100.0% | 56.9% | |
| 100.0% | 113.4% | 4,174.3% | 10,290.4% | 78,096.7% | 158.8% | 570.9% | 452.2% | 262.2% | 110.8% | 100.0% | 169.7% | 149.3% | |
| 280.9% | 24.1% | 1,703.9% | 3,548.9% | 29,652.5% | 53.4% | 287.1% | 359.4% | 163.3% | 45.9% | 361.5% | 97.6% | 96.8% | |
| 1,011.7% | 137.5% | 5,878.1% | 13,839.4% | 105,127.9% | 93.4% | 1,164.2% | 1,088.3% | 163.3% | 156.7% | 966.1% | 256.0% | 231.6% | |
| -940.1% | -39.9% | -5,902.3% | -14,016.2% | -107,649.2% | -152.2% | -1,635.1% | -1,440.6% | -325.4% | -56.7% | -883.2% | -156.0% | -174.7% | |
| – | 5.8% | 0.0% | 0.0% | 0.0% | – | 47.6% | 56.5% | 31.8% | 26.8% | 37.9% | 8.9% | 23.8% | |
| -843.7% | -31.4% | -5,458.1% | -13,178.8% | -101,870.5% | -148.3% | -1,633.5% | -1,487.8% | -333.0% | -22.7% | -882.4% | -153.3% | -157.3% | |
| -28.4% | 17.2% | 0.0% | – | 3,157.4% | – | – | – | – | – | – | – | – | |
| -843.7% | -31.4% | -5,458.1% | -13,178.8% | -101,870.5% | -148.3% | -1,633.5% | -1,487.8% | -333.0% | -22.7% | -882.4% | -153.3% | -157.3% | |
| -815.3% | -29.0% | -5,334.0% | -12,901.9% | -99,249.2% | -107.8% | -1,544.8% | -1,380.1% | -291.6% | -21.3% | -827.5% | -164.2% | -149.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.